𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Waiting List Removal Rates Among Patients with Chronic and Malignant Liver Diseases

✍ Scribed by R. B. Freeman; E. B. Edwards; A. M. Harper

Book ID
114803901
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
202 KB
Volume
6
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Morbidity and mortality from chronic hep
Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus–related chronic liver diseases
✍ Dr. Anna S. F. Lok; Ching-Lung Lai; Hau-Tim Chung; Johnson Y. N. Lau; Elsie K. Y πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 508 KB

Three-hundred forty-one HBsAg-positive family members of 152 patients with chronic hepatitis B virus infection (47 asymptomatic carriers, 59 with chronic hepatitis, 17 with cirrhosis and 29 with hepatocellular carcinoma) were prospectively studied to determine the morbidity and mortality from chroni

Changes in hepatitis A and B vaccination
Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population
✍ Zobair M. Younossi; Maria Stepanova πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

Professional societies recommend hepatitis A and hepatitis B immunization for individuals with chronic liver disease (CLD), but the degree of implementation is unknown. Data were obtained from the National Health and Nutrition Examination Surveys (NHANES) conducted in 1999-2008. For the entire study